TTP Labtech will Showcase its Latest Automated Technology Innovations in Europe
News May 21, 2012
TTP Labtech will showcase its latest innovations for the automation market at the European Laboratory Automation (ELA) conference for the second year. With new products across the liquid handling mosquito® range, biobanking and automated solvent monitoring, TTP’s broad portfolio spans a wide spectrum of benchtop automation requirements. Stop by booth F1 to see the products in action and enter the ‘guess the level’ competition.
As innovative developers of tools to enhance drug discovery, eliminate manual work, increase efficiency and provide robust data, TTP Labtech will display:
• mosquito® HV for the accurate handling of low volume serial dilutions and assay plate preparations across the 500 nL to 5 µL range
• arktic -20 oC/-80 oC automated store, which has the capacity to hold up to 95,000 0.5 mL tubes and still fit neatly into a small footprint
• aequus, the automated non-contact sensor, allows analytical chemists to keep track of both solvent use and waste overflow of analytical instruments
TTP Labtech will also be presenting several posters, including ‘Rapid profiling of multiple toxicity indicators using a laser scanning imaging cytometer’ in collaboration with Life Technologies. This details the use of the acumen® ex3 to provide a measure of toxicity in every cell of every microplate well, thus enabling the identification of toxicity issues earlier in the drug discovery pipeline.
Heart-on-a-chip Manufactured More Efficiently to Speed Up Drug TestingNews
Testing new clinical drugs' effect on heart tissue could become quicker and more straightforward, thanks to new research from Harvard University.
The study, sets out a new, faster method for manufacturing a 'heart-on-a-chip', which can be used to test the reaction of heart tissue to external stimuli.
PPD and Quotient Sciences Form Innovative Partnership to Accelerate Pediatric Drug DevelopmentNews
Will shorten timelines, reduce costs and simplify contracting process in pediatric programs.READ MORE
Glythera Appoints Chief Scientific Officer and Strengthens SABNews
Dr Robert Lutz appointed as CSO to support development of next-generation PermaLink® Antibody Drug Conjugates. Dr Jon Roffey appointed to Scientific Advisory Board.READ MORE